YH-53 - ≥98% , CAS No.1471484-62-4

CAS: 1471484-62-4 Cat. No.: Y647046 Fórmula: C30H33N5O5S Peso molecular: 575.68
Disponível para encomenda
GRAU & PUREZA ≥98%
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Tamanho
USA
Alemanha (EU)*
Preço
Qtd
5mg
Y647046-5mg
Sob encomenda · 8–12 semanas
1000,90US$
10mg
Y647046-10mg
Sob encomenda · 8–12 semanas
1700,90US$
25mg
Y647046-25mg
Sob encomenda · 8–12 semanas
3300,90US$
50mg
Y647046-50mg
Sob encomenda · 8–12 semanas
5200,90US$
Enter a quantity for the sizes you want to add.

Visão geral

YH-53 is a potent 3CL pro inhibitor with K i values of 6.3 nM, 34.7 nM for SARS-CoV-1 3CL pro and SARS-CoV-2 3CL pro , respectively. YH-53 strongly blocks the SARS-CoV-2 replication. YH-53 is a peptidomimetic compound with a unique benzothiazolyl ketone. YH-53 has the potential for COVID-19 research

In Vitro

YH-53 (1-25 μM; for 24 h) efficiently reduces copies of total RNA with increased concentrations in VeroE6/TMPRSS2 cells. YH-53 (1, 5, 10, 15, 20, 25 μM; for 48 h) with 10 μM completely blocks the viral proliferation against SARS-CoV-2 were examined by a cytopathic effect (CPE) assay in Vero cells. YH-53 (10, 100 μM; for 24 h) has no cytotoxicity with a CC 50 value of >100 μM in vero cells. YH-53 (10 μM) moderately inhibits CYP1A2, CYP2D6, and CYP2C8 (26.6%, 38.0%, 66.4%, respectively). YH-53 has no inhibition on CYP2C9 and CYP3A4. YH-53 inhibits SARS-CoV 3CL pro with an IC 50 of 0.74 μM. MCE has not independently confirmed the accuracy of these methods. They are for reference only. RT-PCRCell Line: VeroE6/TMPRSS2 cells Concentration: 1, 5, 10, 15, 20, 25 μM Incubation Time: 24 hours Result: Efficiently reduced copies of total RNA.

In Vivo

YH-53 (0.1 mg/kg; iv) has a T 1/2 of 2.97 hours, an AUC 0–∞ of 19.7 ng•h/mL, a V d of 3.51 L/kg in rats . YH-53 (0.5 mg/kg; oral) has a T 1/2 of 9.64 hours, an AUC 0–∞ of 3.49 ng•h/mL, a C max of 1.08 ng/mL in rats . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Rats Dosage: 0.1 mg/kg (Pharmacokinetic Analysis) Administration: IV Result: Had a T 1/2 of 2.97 hours, an AUC 0–∞ of 19.7 ng•h/mL, a V d of 3.51 L/kg.

Form:Solid

IC50& Target:Ki: 6.3 nM (SARS-CoV-1 3CL pro ) and 34.7 nM (SARS-CoV-2 3CL pro )

Especificações

Especificações e pureza
≥98%
Mecanismos bioquímicos e fisiológicos
YH-53 is a potent 3CL pro inhibitor with K i values of 6.3 nM, 34.7 nM for SARS-CoV-1 3CL pro and SARS-CoV-2 3CL pro , respectively. YH-53 strongly blocks the SARS-CoV-2 replication. YH-53 is a peptidomimetic compound with a unique benzothiazolyl ketone.
Condições de armazenamento de armazenamento
Store at -20°C
Enviado em
Ice chest + Ice pads
Este produto requer transporte de cadeia fria. Serviços terrestres e outros serviços econômicos não estão disponíveis.
Pureza
≥98%
Nomes e identificadores
SMILES
COC1=C2C(NC(C(N[C@@H](CC(C)C)C(N[C@@H](C[C@H]3C(NCC3)=O)C(C4=NC5=CC=CC=C5S4)=O)=O)=O)=C2)=CC=C1
Peso molecular
575.68

Dados avançados

Certificados(CoA,COO,BSE/TSE e Mapa de Análise)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Propriedades químicas e físicas
SolubilidadeDMSO : 50 mg/mL (86.85 mM; Need ultrasonic)
Calculadoras de soluções
Revisões

Avaliações dos Clientes

Deseja que lhe enviemos uma mensagem quando tivermos descontos disponíveis?

Lembrar-me mais tarde

Obrigado! Por favor, verifique a sua caixa de entrada de e-mail para confirmar.

Ops! As notificações estão desativadas.